FDA Approves Opiant's Nasal Spray 'Opvee' To Reverse Opioid Overdose
23/5 04:05
(RTTNews) - The U.S. Food and Drug Administration approved Opiant Pharmaceuticals' Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older....